Skip to content

Assessment of the Prosthetic System Impact on Mental Workload in Above-knee Lower Limb Amputees.

Evaluation of Medical Benefit of a New Prosthetic Leg Designed to Decrease Mental Workload in People With Lower Limb Amputation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06635655
Acronym
INCREMENT
Enrollment
9
Registered
2024-10-10
Start date
2025-02-21
Completion date
2026-12-31
Last updated
2025-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Limb Amputation Above Knee (Injury)

Keywords

microprocessor controlled, lower limb prosthesis, mental workload

Brief summary

New generation of lower limb prosthesis provide improved functionalities. They are usually studied in the scope of biomechanics, sometimes PROMs like quality of life. Following users feedback, it is desirable to better understand why and how mental workload is impacted by new technologies or features. This clinical investigation will try to measure a difference between different prosthetic systems, in lab and in daily life.

Detailed description

Multicentric, national, observational, prospective study, using AB type SCED.

Interventions

None listed

Sponsors

Proteor Group
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 84 Years
Healthy volunteers
No

Inclusion criteria

* above-knee lower limb amputation * using an above-knee prosthesis with prosthetic knee and foot * eligible to use Synsys * able to design therapeutic objectives for the GAS * having a smartphone

Exclusion criteria

* protected person * pregnant or breast-feeding lady * knee-to-ground height lower than 43cm * weighting more than 125kg * using their prosthesis for less than 2 weeks * not covered by health insurance * aged less than 18 or more than 84 years old * bilateral amputee or hip disarticulated

Design outcomes

Primary

MeasureTime frameDescription
Goal Attainment Scale (GAS)From enrollment to the end of treatment at 8 weeksScale from -3 to +2. The higher the better. -3 being a deterioration, -2 being the baseline, 0 the objective, +2 the maximum

Secondary

MeasureTime frameDescription
L-test and Dual-task L-testInitial visit, at 4 weeks, and at 8 weeksTo assess locomotor capacity in divided attention on a short period
Two-minute walk test (2MWT) and 2MWT in divided attentionInitial visit, at 4 weeks, and at 8 weeksto assess locomoto capacity and mental worload during a 2-minute exercise
Activity Balance Confidence Scale (ABC-scale)at 4 weeks, and at 8 weeksPatient reported balance confidence Scale from 0% (minimum) to 100% (maximum), the higher the better.
Prosthesis Evaluation Questionnaire (PEQ-A)at 4 weeks, and at 8 weeksPatient reported satisfaction Visual Analog Scale from 0% (minimum) to 100% (maximum) The higher the better
Stumbles and fallsat 4 weeks, and at 8 weeksSelf-reported number The lower the better

Countries

France

Contacts

Primary ContactRenaud Urbinelli
rurbinelli@clin-experts.fr0033658687286

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026